Proven Industry Veteran Linwood “Woody” Staub Joins Soluble Systems as President, Chief Operating Officer and Board Member
NEWPORT NEWS, VA, June 4, 2015 – Soluble Systems, LLC, a rapidly growing biotech company focused on commercializing regenerative therapies for chronic wounds, is pleased to announce the appointment of Linwood “Woody” Staub as President and Chief Operating Officer and continuing Board Member. Most immediately, Mr. Staub will lead the Company’s national expansion of TheraSkin®, a highly successful real human skin wound therapy, with full responsibility for sales, marketing, reimbursement, and sales support functions.
Commenting on the opportunity ahead, Mr. Staub said, “I am extremely pleased to be joining Soluble Systems at such a pivotal time in the company’s history. Soluble Systems’ lead product, TheraSkin®, provides an excellent solution for hard to heal wounds and represents an excellent value proposition for caregivers and providers alike. Since I have been a Board Member during the start-up of TheraSkin®, I know we have a very capable team ready to make TheraSkin® available to millions of additional patients.”
Mr. Staub has spent 30 highly successful years in the medical device space. Most recently he built and sold two start-up ventures. As Founder and Owner, he built CMJ Medical, a sports medicine distributorship, into the largest, fastest growing agency within DePuy Mitek with over $53 Million dollars in revenue. This business was recently purchased by Johnson & Johnson. Concurrently, he started SSN Partners, a medical device consulting practice, which lead a single product start up to $22 Million in 5 years, ending in a sale for over $100 Million.
Prior to CMJ, Woody held the position of World Wide President of KCI’s VAC division, with over $1.6 Billion in sales. Woody began his career with Johnson & Johnson, holding positions of increasing responsibility in Ethicon, Ethicon Endo Surgery, Indigo, Mitek, Wound Management/Bio-Surgery and Women’s Health and Urology. He has extensive experience internationally, including 6 years in Tokyo and 3 years living in London covering Europe/Middle East and Africa as General Manager of the J&J Wound Management/Bio-surgical division.
Woody graduated from Randolph-Macon College, with a degree in Business and Economics and holds a fellowship degree from Wharton at the University of Pennsylvania.
About TheraSkin: TheraSkin is a biologically active cryo-preserved human skin allograft for non-responsive chronic wounds. Its fully developed extracellular matrix (ECM) and living cells provide an “at-ready” supply of human growth factors, cytokines and collagen to jumpstart wound healing. TheraSkin provides necessary growth factors and cytokines to treat chronic wounds. It also provides a large quantity of essential human collagens in appropriate ratios to support healing. This allows TheraSkin to be used on more severe wounds with exposed bone, tendon, joint capsules or muscle.
For more information on TheraSkin and Soluble Systems, LLC, visit www.solublesystems.com.